About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
464 genotypes with 477 annotations displayed of selected term and subterms
Searched Term: abnormal double-positive T cell morphology
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor
(FVBTac.129P2-Abcb1btm1Bor Abcb1atm1Bor) 		increased double-positive T cell number J:102640
Adatm1Mw/Adatm1Mw
Tg(PLADA)4118Rkmb/0
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased double-positive T cell number J:73418
Adam10tm1.1Khr/Adam10tm1.1Khr
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N) 		decreased double-positive T cell number J:179060
Adam10tm1Zhu/Adam10tm1.1Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J) 		decreased double-positive T cell number J:139042
Adam10tm1Zhu/Adam10tm1Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL/J) 		decreased double-positive T cell number J:139042
Aff1tm1Cim/Aff1tm1Cim
(involves: 129P2/OlaHsd * BALB/c) 		decreased double-positive T cell number J:63253
Akt1tm1Pnt/Akt1tm1Pnt
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Akt3tm1Mbb/Akt3tm1Mbb
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:135903
Akt1tm1Pnt/Akt1tm1Pnt
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:135903
Akt1tm1Pnt/Akt1tm1Pnt
Akt3tm1Mbb/Akt3tm1Mbb
Tg(Lck-cre)1Cwi/0
(Not Specified) 		decreased double-positive T cell number J:135903
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi
Fancd2tm1Hou/Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N) 		increased double-positive T cell number J:193232
Arhgdiatm1Ytk/Arhgdiatm1Ytk
Arhgdibtm1Miyo/Arhgdibtm1Miyo
(involves: 129S/SvEv) 		decreased double-positive T cell number J:140671
Arid5btm1Pjh/Arid5btm1Pjh
(involves: 129S4/SvJae * BALB/c) 		decreased double-positive T cell number J:70658
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6) 		decreased double-positive T cell number J:285931
Atmtm1Awb/Atmtm1Awb
(either: 129S6/SvEvTac-Atmtm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss)) 		decreased double-positive T cell number J:34193
increased double-positive T cell number J:34193
Atmtm1Awb/Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb/J) 		increased double-positive T cell number J:226414
Atmtm1Led/Atmtm1Led
(involves: 129S6/SvEvTac * Black Swiss) 		increased double-positive T cell number J:36561
B2mtm1Jae/B2mtm1Jae
Zbtb7btm1Litt/Zbtb7btm1.2Litt
(involves: 129S2/SvPas * C57BL/6) 		abnormal double-positive T cell morphology J:141144
Bcl2tm1Sjk/Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6) 		decreased double-positive T cell number J:15224
Bcl2l1tm1Ywh/Bcl2l1tm1Ywh
Mcl1tm1Ywh/Mcl1tm1Ywh
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:137400
Bcl2l1tm1Ywh/Bcl2l1tm1Ywh
Tg(Lck-cre)548Jxm/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA) 		decreased double-positive T cell number J:99012
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6) 		decreased double-positive T cell number J:58641
Bcl10tm1Mak/Bcl10tm1Mak
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:67297
Bcl11btm1Avram/Bcl11btm1Avram
Tcratm1Mom/Tcratm1Mom
Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:128515
Bcl11btm1Avram/Bcl11btm1Avram
Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:128515
Bcl11btm1Avram/Bcl11btm1Avram
Tg(Cd4-cre)1Cwi/?
Tg(LCKprBCL2)36Sjk/?
(involves: 129 * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:128515
Bcl11btm1Jpk/Bcl11btm1Jpk
(involves: BALB/c * C57BL/6 * CBA) 		decreased double-positive T cell number J:83651
Bcl11btm2.1Jpk/Bcl11b+
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6) 		decreased double-positive T cell number J:210122
Bhlhe40tm1Tan/Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		decreased double-positive T cell number J:72651
Birc5tm1Wnt/Birc5tm1Emc
Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:87435
Bmi1tm1Brn/Bmi1tm1Brn
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:134271
Bmi1tm1Brn/Bmi1tm1Brn
E2f6tm1Lees/E2f6tm1Lees
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased double-positive T cell number J:134271
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased double-positive T cell number J:63282
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
Tg(TcrLCMV)327Sdz/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased double-positive T cell number J:63282
Bsgtm1.1Znc/Bsgtm1.1Znc
Tg(Lck-cre)19Hhan/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		decreased double-positive T cell number J:207886
Cacnb4lh/Cacnb4lh
(B6EiC3Sn a/A-Cacnb4lh/J) 		decreased double-positive T cell number J:115345
Cadm1Gt(Ayu21-W34)Imeg/Cadm1Gt(Ayu21-W34)Imeg
(involves: C57BL/6 * CBA/JNCrlj) 		increased double-positive T cell number J:178612
Cbfbtm1Itan/Cbfbtm1Itan
Rr94tm3.1Litt/Rr94tm3.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		abnormal double-positive T cell morphology J:158962
decreased double-positive T cell number J:158962
increased double-positive T cell number J:158962
Cbfbtm1Itan/Cbfbtm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased double-positive T cell number J:158962
Cbfbtm1Itan/Cbfbtm1Itan
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd) 		abnormal double-positive T cell morphology J:125953
Cbfbtm1Spe/Cbfbtm2.1Spe
(involves: 129S4/SvJae) 		decreased double-positive T cell number J:124224
Cbfbtm2.1Spe/Cbfbtm2.1Spe
(involves: 129S4/SvJae) 		decreased double-positive T cell number J:124224
Cbx4tm1.1Gxu/Cbx4tm1.2Gxu
Tg(Foxn1-cre)1Tbo/0
(involves: 129S2/SvPas * C57BL/6J) 		decreased double-positive T cell number J:194053
Ccnd3tm1.1(Ccnd2)Iaai/Ccnd3tm1.1(Ccnd2)Iaai
(involves: 129S6/SvEvTac) 		decreased double-positive T cell number J:192031
Ccnd3tm1Pisc/Ccnd3tm1Pisc
(Not Specified) 		decreased double-positive T cell number J:88120, J:192031
Ccnd3tm1Pisc/Ccnd3tm1Pisc
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor) 		decreased double-positive T cell number J:192031
Ccnd3tm1Pisc/Ccnd3tm1Pisc
Rb1tm2Brn/Rb1tm2Brn
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA) 		decreased double-positive T cell number J:192031
Ccnd3tm2.1Pisc/Ccnd3tm2.1Pisc
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		decreased double-positive T cell number J:192032
Ccr6tm1Lira/Ccr6tm1Lira
(involves: 129 * C57BL/6) 		increased double-positive T cell number J:76461
Ccr9tm1.1Mal/Ccr9tm1.1Mal
(involves: 129S2/SvPas * C57BL/6) 		decreased double-positive T cell number J:72386
Cd3etm1.1Geno/Cd3etm1.1Geno
(involves: C57BL/6) 		abnormal double-positive T cell morphology J:192604
Cd3etm1.1Geno/Cd3etm1.1Geno
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6) 		decreased double-positive T cell number J:192604
Cd3etm1.1Lov/Cd3etm1.1Lov
(Not Specified) 		decreased double-positive T cell number J:72144
Cd3etm1Cpt/Cd3etm1Cpt
(involves: 129S4/SvJae * C57BL/6) 		decreased double-positive T cell number J:54756
Cd3etm1Cpt/Cd3etm1Cpt
Tg(CD3E)26Cpt/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		decreased double-positive T cell number J:54756
Cd3etm1Lov/Cd3etm1Lov
(involves: 129S1/Sv * 129X1/SvJ) 		decreased double-positive T cell number J:72144
Cd4maat/Cd4maat
(C57BL/6JAnu-Cd4maat/Apb) 		abnormal double-positive T cell morphology J:104190
Cd4sesh/Cd4sesh
(C57BL/6JAnu-Cd4sesh/AnuApb) 		abnormal double-positive T cell morphology J:104190
Cd4tm1Jrp/Cd4tm1Jrp
(either: B6.129S2-Cd4tm1Jrp or B10.Cg-Cd4tm1Jrp) 		decreased double-positive T cell number J:45168
Cd4tm1Mak/Cd4tm1Mak
Cd8atm1Mak/Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:12572
Cd5tm1.1Chra/Cd5tm1.1Chra
(involves: C57BL/6 * FVB/N) 		decreased double-positive T cell number J:189919
Cd5ltm1Nto/Cd5ltm1Nto
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal double-positive T cell morphology J:52195
Cd7tm1Bfh/Cd7tm1Bfh
(involves: 129 * C57BL/6) 		increased double-positive T cell number J:48758
Cd7tm1Bfh/Cd7tm1Bfh
(B6.129-Cd7tm1Bfh) 		increased double-positive T cell number J:48758
Cd8atm1Asin/Cd8atm1Asin
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		abnormal double-positive T cell morphology J:126026
Cd8b1tm1Litt/Cd8b1+
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6J * DBA/2) 		decreased double-positive T cell number J:112551
Cd40lgtm1Flv/Cd40lgtm1Flv
(involves: 129S2/SvPas * C57BL/6) 		decreased double-positive T cell number J:25010
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm) 		increased double-positive T cell number J:123582
Cd79atm2Pld/Cd79atm2Pld
(BALB/c-Cd79atm2Pld) 		decreased double-positive T cell number J:87492
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae * BALB/c) 		decreased double-positive T cell number J:112266
Cd247tm1Lov/Cd247tm1Lov
(involves: 129S4/SvJae) 		decreased double-positive T cell number J:14170
Cd247tm1Mal/Cd247tm1Mal
(either: C57BL/6-Cd247tm1Mal or (involves: BALB/c * C57BL/6)) 		decreased double-positive T cell number J:15272
Cd247tm1Mal/Cd247tm1Mal
(involves: C57BL/6) 		decreased double-positive T cell number J:110847
Cd247tm1Mal/Cd247tm1Mal
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas * C57BL/6) 		decreased double-positive T cell number J:110847
Cd247tm1Mhu/Cd247tm1Mhu
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased double-positive T cell number J:15579
Cd247tm1Tks/Cd247tm1Tks
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:15271
Cdk6tm1Phin/Cdk6tm1Phin
(involves: 129S4/SvJae) 		decreased double-positive T cell number J:144975
Cdk6tm1Phin/Cdk6tm1Phin
(involves: 129S4/SvJae * C57BL/6) 		decreased double-positive T cell number J:174697
Cdk6tm2.1Phin/Cdk6tm2.1Phin
(involves: 129 * C57BL/6 * FVB/N) 		decreased double-positive T cell number J:174697
Cdk6tm4.1Phin/Cdk6tm4.1Phin
(involves: 129 * C57BL/6 * FVB/N) 		decreased double-positive T cell number J:174697
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased double-positive T cell number J:71394
Chd4tm1.1Kge/Chd4tm1.1Kge
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * SJL) 		decreased double-positive T cell number J:109547
Chd4tm1.2Kge/Chd4tm1.2Kge
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		decreased double-positive T cell number J:109547
Ciitatm1Jpyt/Ciitatm1Jpyt
(involves: 129P2/OlaHsd * C57BL/6J) 		increased double-positive T cell number J:57100
Col10a1tm1Bhr/Col10a1tm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased double-positive T cell number J:62230
Copatm1.1Shum/Copa+
(B6(CBA)-Copatm1.1Shum) 		decreased double-positive T cell number J:288425
Cops5tm1Rpar/Cops5tm1Rpar
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL) 		decreased double-positive T cell number J:132114
Cpa3tm3(icre)Hrr/Cpa3+
Notch1tm1Agt/Notch1tm1Agt
(involves: 129 * C57BL/6) 		decreased double-positive T cell number J:143731
Crebbptm1Jvd/Crebbptm1Jvd
Ep300tm2Pkb/Ep300tm2Pkb
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased double-positive T cell number J:105505
Crebbptm1Jvd/Crebbptm1Jvd
Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA) 		increased double-positive T cell number J:105505
Crebbptm1Jvd/Crebbptm1Jvd
Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * FVB) 		decreased double-positive T cell number J:88323
Ctcftm2Gal/Ctcftm2Gal
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * C57BL/10) 		decreased double-positive T cell number J:143271
Ctcftm2Gal/Ctcftm2Gal
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:143271
Ctcftm2Gal/Ctcftm2Gal
Tg(Lck-cre)1Cwi/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * DBA/2J) 		decreased double-positive T cell number J:143271
Ctcftm2Gal/Ctcftm2Gal
Tg(Lck-cre)1Cwi/0
Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:143271
Ctla4tm1All/Ctla4tm1All
(involves: 129S1/Sv * 129X1/SvJ) 		decreased double-positive T cell number J:42481
Ctla4tm1Shr/Ctla4tm1Shr
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		decreased double-positive T cell number J:30393
Ctsdtm1.1Thre/Ctsdtm1.1Thre
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: C57BL/6 * C57BL/6N * CBA * SJL) 		decreased double-positive T cell number J:227618
Ctsdtm1.1Thre/Ctsdtm1.1Thre
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL) 		decreased double-positive T cell number J:227618
Ctsdtm1Cptr/Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd)) 		decreased double-positive T cell number J:28201
Ctsetm1Kjy/Ctsetm1Kjy
(involves: C57BL/6) 		increased double-positive T cell number J:108745
Cux1tm1Rhsc/Cux1tm1Rhsc
(involves: 129S1/Sv * C57BL/6J) 		decreased double-positive T cell number J:100055
Cxcr4tm1Tng/Cxcr4tm1Tng
(B6.Cg-Cxcr4tm1Tng) 		decreased double-positive T cell number J:82996
Cyldtm1Scs/Cyldtm1Scs
(involves: 129S1/Sv * 129X1/SvJ) 		increased double-positive T cell number J:112392
Dcktm1.1Radu/Dcktm1.1Radu
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * C57BL/6J) 		decreased double-positive T cell number J:158373
Dclre1cm1Brck/Dclre1cm1Brck
(involves: C57BL/6) 		decreased double-positive T cell number J:207533
Dclre1ctm1Fwa/Dclre1ctm1Fwa
(involves: 129S6/SvEvTac) 		decreased double-positive T cell number J:147864
Dclre1ctm1Jsek/Dclre1ctm1Jsek
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased double-positive T cell number J:147864
Dclre1ctm2.2Jpdv/Dclre1ctm2.2Jpdv
(B6.129S2-Dclre1ctm2.2Jpdv) 		decreased double-positive T cell number J:153841
Dffbtm1Osa/Dffbtm1Osa
Dnase2atm1Osa/Dnase2atm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased double-positive T cell number J:81474
Dll4tm1Frad/Dll4tm1Frad
Foxn1tm3(cre)Nrm/Foxn1+
(B6.Cg-Dll4tm1Frad Foxn1tm3(cre)Nrm) 		decreased double-positive T cell number J:143472
Dll4tm1Kaho/Dll4tm1Kaho
Tg(Foxn1-cre)8Ghr/0
(involves: C57BL/6 * DBA/2) 		decreased double-positive T cell number J:143473
Dnajc11spc/Dnajc11spc
(B6.Cg-Dnajc11spc) 		decreased double-positive T cell number J:221543
Dnmt3btm1Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6) 		decreased double-positive T cell number J:106540
Dock2tm1Tsas/Dock2tm1Tsas
Tg(Tcra2B4)1Mmd/?
Tg(Tcrb2B4)1Mmd/?
(involves: C57BL/6) 		decreased double-positive T cell number J:84581
Droshatm1Litt/Droshatm1.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		decreased double-positive T cell number J:138683
Dsg3sqk/Dsg3sqk
(C57BL/6-Dsg3sqk) 		decreased double-positive T cell number J:219200
Dyrk1atm1Jdc/Dyrk1atm1Jdc
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6J * C57BL/6NTac * CBA/J) 		decreased double-positive T cell number J:223138
E2f1tm1Meg/E2f1tm1Meg
(either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6)) 		abnormal double-positive T cell morphology J:33100
E2f1tm1Meg/E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg) 		abnormal double-positive T cell morphology J:93708
decreased double-positive T cell number J:93708
E2f4tm1Jrn/E2f4tm1Jrn
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:64192
Eef1a1tm2Arge/Eef1a1+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		abnormal double-positive T cell morphology J:197167
Efnb1tm1.1Jwu/Efnb1tm1.1Jwu
Efnb2tm1.1Jwu/Efnb2tm1.1Jwu
Tg(Lck-cre)I540Jxm/0
(B6.Cg-Efnb2tm1.1Jwu Efnb1tm1.1Jwu Tg(Lck-cre)I540Jxm) 		decreased double-positive T cell number J:178148
Elavl1tm1Dkon/Elavl1tm1Dkon
Tg(Lck-cre)I57Jxm/0
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm) 		increased double-positive T cell number J:148866
Elavl1tm1Thla/Elavl1tm1Thla
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
(involves: 129) 		decreased double-positive T cell number J:155109
Ep300tm2Pkb/Ep300tm2Pkb
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased double-positive T cell number J:105505
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J) 		increased double-positive T cell number J:110416
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		increased double-positive T cell number J:110416
Ets1tm1.1Dds/Ets1tm1.1Dds
(129S6/SvEvTac-Ets1tm1.1Dds) 		increased double-positive T cell number J:121460
Ewsr1tm1Sblee/Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss) 		decreased double-positive T cell number J:122058
Ezh2tm2Sho/Ezh2tm2.1Sho
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		decreased double-positive T cell number J:182211
Ezh2tm2Sho/Ezh2tm2Sho
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		decreased double-positive T cell number J:182211
Faddtm1Wnt/Faddtm1Wnt
Tg(Fadd)33Wnt/0
Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA * ICR) 		decreased double-positive T cell number J:69617
Fastm1Ach/Fastm1Ach
Tg(GZMB-cre)1Jcb/?
(involves: C57BL/6 * FVB/N) 		increased double-positive T cell number J:123556
Fastm1Ach/Fastm1Ach
Tg(Lck-cre)548Jxm/?
(involves: C57BL/6 * CBA) 		increased double-positive T cell number J:123556
Fbxw7tm1Kei/Fbxw7tm1Kei
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased double-positive T cell number J:128523
Fbxw7tm1Kei/Fbxw7tm1Kei
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6) 		increased double-positive T cell number J:128523
Fbxw7tm1Kei/Fbxw7tm1Kei
Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6) 		increased double-positive T cell number J:128523
Flt3tm1Irl/Flt3tm1Irl
KitW/KitW-v
(involves: 129S/SvEv * C57BL/6) 		decreased double-positive T cell number J:27238
Fostm1Wag/Fostm1Wag
(involves: 129S2/SvPas * C57BL/6) 		decreased double-positive T cell number J:3493
Foxn1tm1.1Cbln/Foxn1tm1.1Cbln
(involves: 129P2/OlaHsd * C57BL/6) 		increased double-positive T cell number J:177992
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL) 		decreased double-positive T cell number J:159773
Foxn1tm1Nrm/Foxn1tm1Nrm
(involves: 129X1/SvJ * C57BL/6J) 		decreased double-positive T cell number J:86255
Foxo1tm1.1Stlp/Foxo1tm1.1Stlp
Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae) 		decreased double-positive T cell number J:154205
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased double-positive T cell number J:125405
Foxp3tm1Ayr/Foxp3tm1Ayr
Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:125405
Foxp3tm2Ayr/?
Zap70rps/Zap70rps
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal double-positive T cell morphology J:211510
Fyntm1Rmp/Fyntm1Rmp
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas) 		decreased double-positive T cell number J:37940
Fyntm1Yik/Fyntm1Yik
Ptk2tm1Lfr/Ptk2+
(involves: 129X1/SvJ * C57BL/6 * CBA) 		decreased double-positive T cell number J:110771
Gata3tm1Iho/Gata3tm1Iho
Tg(DO11.10)10Dlo/0
Tg(Lck-cre)1Cwi/0
(involves: BALB/c * C3H * C57BL/6) 		decreased double-positive T cell number J:86996
Gata3tm1Iho/Gata3tm1Iho
Tg(Lck-cre)1Cwi/0
(involves: BALB/c) 		decreased double-positive T cell number J:86996
Gata3tm2Jeng/Gata3tm2Jeng
(Not Specified) 		abnormal double-positive T cell morphology J:155686
Gba1tm1.1Pmis/Gba1tm1.1Pmis
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		decreased double-positive T cell number J:167081
Gba1tm1.1Pmis/Gba1tm1.2Pmis
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		decreased double-positive T cell number J:167081
Gmnntm1.1Kio/Gmnntm1.2Kio
Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca) 		decreased double-positive T cell number J:159657
Grap2tm1Amch/Grap2tm1Amch
Lcp2tm1.1Wz/Lcp2tm1.1Wz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased double-positive T cell number J:150304
Grb2tm1.1Hua/Grb2tm1.1Hua
Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6) 		decreased double-positive T cell number J:161294
Grb2tm1.1Hua/Grb2tm1.1Hua
Tg(Lck-cre)1Jtak/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J) 		increased double-positive T cell number J:161294
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sortm1(DTA)Lky
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:133382
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		increased double-positive T cell number J:157757
Gt(ROSA)26Sortm1(ITK/SYK)Jrld/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:160931
Gt(ROSA)26Sortm1(rtTA)Awu/Gt(ROSA)26Sortm1(rtTA)Awu
Xisttm1Awu/Y
(involves: 129S4/SvJae) 		decreased double-positive T cell number J:112954
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N) 		decreased double-positive T cell number J:202090
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA) 		decreased double-positive T cell number J:202090
H2b/H2b
Ptcratm1Vbo/Ptcratm1Vbo
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:131357
H2b/H2b
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		abnormal double-positive T cell morphology J:81564
decreased double-positive T cell number J:131357
H2u/H2u
Tg(TCRA)B1Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg/J) 		decreased double-positive T cell number J:92992
H2u/H2u
Tg(TCRA)B1Jg/?
Tg(TCRB)C14Jg/?
(involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J) 		decreased double-positive T cell number J:92991
H2u/H2u
Tg(TCRA)B1Jg/0
Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg) 		abnormal double-positive T cell morphology J:92992
decreased double-positive T cell number J:92992
H2u/H2u
Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRB)C14Jg/J) 		abnormal double-positive T cell morphology J:92992
Hax1tm1.1Gach/Hax1tm1.1Gach
(involves: BALB/c) 		decreased double-positive T cell number J:174159
Hax1tm1Jni/Hax1tm1Jni
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:132627
Hcls1tm1Wtn/Hcls1tm1Wtn
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		decreased double-positive T cell number J:28146
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc
Hdac2tm1.1Shmc/Hdac2+
Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd) 		decreased double-positive T cell number J:194769
increased double-positive T cell number J:194769
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc
Hdac2tm1.1Shmc/Hdac2tm1.1Shmc
Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd) 		decreased double-positive T cell number J:194769
increased double-positive T cell number J:194769
Hes1tm1.1Frad/Hes1tm1.1Frad
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		decreased double-positive T cell number J:167000
Hivep3tm1Lcw/Hivep3tm1Lcw
(chimera involves: 129S/SvEv * 129X1/SvJ) 		decreased double-positive T cell number J:79652
Hnrnpltm1.1Tmo/Hnrnpltm1.1Tmo
Tg(Lck-cre)548Jxm/0
(B6.Cg-Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm) 		decreased double-positive T cell number J:188749
Htra2mnd2/Htra2mnd2
(involves: C57BL/6J) 		decreased double-positive T cell number J:132627
Id3tm1Cmu/Id3tm1Cmu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal double-positive T cell morphology J:59969
Ightm1(PAX5)Mbu/Igh+
(B6.Cg-Ightm1(PAX5)Mbu) 		decreased double-positive T cell number J:118111
Ightm1(PAX5)Mbu/Ightm1(PAX5)Mbu
(B6.Cg-Ightm1(PAX5)Mbu) 		decreased double-positive T cell number J:118111
Ikzf1plstc/Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc) 		decreased double-positive T cell number J:84569
Ikzf1tm1.1(Pax5)Mbu/Ikzf1+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:118111
Ikzf1tm2.1Smale/Ikzf1tm2.1Smale
(B6.Cg-Ikzf1tm2.1Smale) 		decreased double-positive T cell number J:208211
Ikzf1tm2Kge/Ikzf1tm2Kge
(involves: 129S4/SvJae) 		decreased double-positive T cell number J:37317
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:37220
Il2rbtm1Mak/Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas)) 		decreased double-positive T cell number J:25940
Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6) 		decreased double-positive T cell number J:24117
Il6sttm1Thir/Il6sttm1Thir
(involves: 129 * C57BL/6) 		decreased double-positive T cell number J:133059
Il7rtm1Abra/Il7rtm1Abra
(B6.129S4-Il7rtm1Abra) 		increased double-positive T cell number J:125360
Il7rtm1Iku/Il7rtm1Iku
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased double-positive T cell number J:34658
Il7rtm1Imx/Il7rtm1Imx
(B6.129S7-Il7rtm1Imx) 		decreased double-positive T cell number J:125360
Irf1tm1Mak/Irf1tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2)) 		increased double-positive T cell number J:64286
Itktm1Litt/Itktm1Litt
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2J) 		increased double-positive T cell number J:31230
Itktm1Litt/Itktm1Litt
Vav1tm2Bbd/Vav1tm2Bbd
(B6.129-Itktm1Litt Vav1tm2Bbd) 		decreased double-positive T cell number J:141390
Itpkbtm1Ssch/Itpkbtm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased double-positive T cell number J:86257
Kitltm3.1Pbes/Kitltm3.1Pbes
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		decreased double-positive T cell number J:157170
Klf13tm1Kren/Klf13tm1Kren
(B6.129-Klf13tm1Kren) 		increased double-positive T cell number J:145839
Kmt2etm1.1Hjf/Kmt2etm1.1Hjf
(B6.129P2-Kmtetm1.1Hjf) 		decreased double-positive T cell number J:145579
Kmt5btm1Jnw/Kmt5btm1Jnw
Kmt5ctm1.1Jnw/Kmt5ctm1.1Jnw
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129/Sv * C57BL/6J * C57BL/10 * CBA/Ca) 		decreased double-positive T cell number J:139510
Krastm4Tyj/Kras+
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
Tg(Flt3-cre)#Ccb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		decreased double-positive T cell number J:247853
Lama2tm1Stk/Lama2tm1Stk
(involves: 129P2/OlaHsd * BALB/c) 		decreased double-positive T cell number J:61802
Lattm1.1Lov/Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased double-positive T cell number J:77099
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas) 		decreased double-positive T cell number J:77098
Lattm1Les/Lattm1.1Wz
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		increased double-positive T cell number J:147946
Lattm1Les/Lattm1Les
Lcp2tm5(Lat/Lcp2)Gak/Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ) 		decreased double-positive T cell number J:147721
Lattm1Les/Lattm1Les
Tg(CD2-LAT2)1Wz/0
(Not Specified) 		decreased double-positive T cell number J:116964
Lattm2.1Mal/Lattm2.1Mal
(involves: 129S2/SvPas) 		decreased double-positive T cell number J:94074
Lattm3.1Mal/Lattm3.1Mal
(involves: 129S2/SvPas) 		decreased double-positive T cell number J:94074
Lattm4.1Mal/Lattm4.1Mal
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:94074
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas) 		decreased double-positive T cell number J:1119, J:110847
Lcp2tm3Gak/Lcp2tm3Gak
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2J) 		increased double-positive T cell number J:132995
Lcp2tm4Gak/Lcp2tm4Gak
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N) 		increased double-positive T cell number J:132995
Lcp2tm5(Lat/Lcp2)Gak/Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ) 		decreased double-positive T cell number J:147721
Lcp2twm/Lcp2twm
(C57BL/6JSfdAnu-Lcp2twm/Anu) 		abnormal double-positive T cell morphology J:104190
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		decreased double-positive T cell number J:157574
Lrrc8atm1.1Geha/Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha) 		decreased double-positive T cell number J:211308
Map3k3tm1Kuro/Map3k3tm1Kuro
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6) 		decreased double-positive T cell number J:147103
Mapk1tm1Hed/Mapk1tm1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased double-positive T cell number J:113280
Mapk1tm1Hed/Mapk1tm1Hed
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		increased double-positive T cell number J:113280
Mapk1tm1Hed/Mapk1tm1Hed
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased double-positive T cell number J:113280
Mapk1tm1Hed/Mapk1tm1Hed
Tg(TcrAND)53Hed/0
(involves: C57BL/6 * DBA/2 * SJL) 		abnormal double-positive T cell morphology J:113280
Matn1tm1Ref/Matn1tm1Ref
Matn2tm1Asz/Matn2tm1Asz
Matn3tm1Asz/Matn3tm1Asz
Matn4tm1.1Asz/Matn4tm1.1Asz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased double-positive T cell number J:237230
Mcl1tm1Yen/Mcl1tm1Yen
(B6.129-Mcl1tm1Yen) 		abnormal double-positive T cell morphology J:146246
Mcl1tm1Yen/Mcl1tm1Yen
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal double-positive T cell morphology J:146246
Mcl1tm1Yen/Mcl1tm1Yen
Tg(TcraTcrb)425Cbn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal double-positive T cell morphology J:146246
Mcl1tm1Ywh/Mcl1tm1Ywh
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased double-positive T cell number J:137400
Mcl1tm1Ywh/Mcl1tm1Ywh
Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA) 		decreased double-positive T cell number J:137400
Mcl1tm2Sjk/Mcl1tm3Sjk
Tg(Lck-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:86906
Mdm2tm1Bay/Mdm2tm1Mep
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased double-positive T cell number J:81065
Mertktm1Gkm/Mertktm1Gkm
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Mertktm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi) 		decreased double-positive T cell number J:147153
Mirc14tm1.1Ankr/Mirc14tm1.1Ankr
(involves: C57BL/6) 		decreased double-positive T cell number J:196134
Mirc14tm1.1Czc/Mirc14tm1.1Czc
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(either: (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor * C57BL/6)) 		decreased double-positive T cell number J:188125
Mirc14tm1.2Czc/Mirc14tm1.2Czc
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)) 		decreased double-positive T cell number J:188125
Mirc14tm1.2Flv/Mirc14tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL) 		decreased double-positive T cell number J:203157
Mmp19tm1Rase/Mmp19tm1Rase
(B6.129P2-Mmp19tm1Rase) 		increased double-positive T cell number J:137128
Msi2Gt(E035H03)Wrst/Msi2Gt(E035H03)Wrst
(B6.129P2-Msi2Gt(E035H03)Wrst) 		decreased double-positive T cell number J:174870
Mtortm1Lgm/Mtortm1Lgm
(involves: 129S1/Sv * C57BL/6) 		decreased double-positive T cell number J:168600
Mybtm1Cgn/Mybtm1.1Cgn
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:91122
Mybtm1Cgn/Mybtm1Cgn
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:91122
Mybtm1Cgn/Mybtm1Cgn
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:91122
Mybtm1Epr/Mybtm1Epr
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:93481
Mybtm1Epr/Mybtm1Epr
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased double-positive T cell number J:93481
Ncaph2nes/Ncaph2nes
(C57BL/6JSfdAnu-Ncaph2nes/Anu) 		decreased double-positive T cell number J:123300
Ncaph2nes/Ncaph2nes
Tg(TcrHEL3A9)1Mmd/0
(C57BL/6-Ncaph2nes Tg(TcrHEL3A9)1Mmd) 		decreased double-positive T cell number J:123300
Nckap1lm1Iri/Nckap1lm1Iri
(involves: C57BL/6) 		decreased double-positive T cell number J:141377
Nfatc1tm1Glm/Nfatc1tm2Glm
(chimera involves: 129S2/SvPas) 		decreased double-positive T cell number J:78376
Nfatc3tm1Glm/Nfatc3tm1Glm
Tg(DO11.10)10Dlo/?
(involves: 129S2/SvPas * BALB/c * C3H * C57BL/6) 		decreased double-positive T cell number J:50124
Nfkb1tm1Bal/Nfkb1tm1Bal
Nfkb2tm1Sbn/Nfkb2tm1Sbn
(involves: 129P2/OlaHsd * 129S4/SvJae) 		decreased double-positive T cell number J:45119
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c) 		increased double-positive T cell number J:154812
Nfkb2tm1Brv/Nfkb2tm1Brv
(involves: 129S1/Sv * C57BL/6) 		decreased double-positive T cell number J:43469
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc
(involves: C57BL/6) 		increased double-positive T cell number J:163686
Nfkbiatm1Bal/Nfkbiatm1Bal
(involves: 129S4/SvJae * C57BL/6J) 		decreased double-positive T cell number J:30058
Nkaptm1.1Viss/Y
Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ) 		decreased double-positive T cell number J:165961
Nlktm1Tbo/Nlktm1Tbo
(129S1/Sv-Nlktm1Tbo) 		decreased double-positive T cell number J:73353
Nmt1tm1.1Poru/Nmt1tm1.1Poru
Nmt2tm1.1Poru/Nmt2tm1.1Poru
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		decreased double-positive T cell number J:226234
Nmt1tm1.1Poru/Nmt1tm1.1Poru
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		decreased double-positive T cell number J:226234
Nmt2tm1.1Poru/Nmt2tm1.1Poru
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		decreased double-positive T cell number J:226234
Noc2ltm1.1Arte/Noc2ltm1.1Arte
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca) 		decreased double-positive T cell number J:216490
Notch1tm1Agt/Notch1tm1Agt
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA) 		decreased double-positive T cell number J:55400
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda
Rag2tm1.1Cgn/Rag2tm1.1Cgn
Tg(Lck-cre)548Jxm/0
Tg(TcrAND)53Hed/0
(B6.Cg-Rag2tm1.1Cgn Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm Tg(TcrAND)53Hed) 		decreased double-positive T cell number J:189951
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda
Tcratm1Mom/Tcratm1Mom
Tg(Lck-cre)548Jxm/0
(B6.Cg-Tcratm1Mom Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm) 		decreased double-positive T cell number J:189951
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda
Tg(Lck-cre)548Jxm/0
(B6.Cg-Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm) 		decreased double-positive T cell number J:189951
Ogttm1Gwh/Y
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased double-positive T cell number J:93112
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased double-positive T cell number J:116017
Pax1un-i/Pax1un-i
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)) 		decreased double-positive T cell number J:100951
Pdia6em1Btlr/Pdia6m1Btlr
(involves: C57BL/6J) 		decreased double-positive T cell number J:288824
Phf20Gt(XN131)Byg/Phf20Gt(XN131)Byg
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:228714
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased double-positive T cell number J:125791
Pla2g6m1Sein/Pla2g6m1Sein
(C57BL/6JJcl-Pla2g6m1Sein) 		decreased double-positive T cell number J:155328
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		increased double-positive T cell number J:157757
Pnpf/Pnpf
(C57BL/6J-Pnpf) 		decreased double-positive T cell number J:39328
Pnpg/Pnpg
(involves: C57BL/6 * DBA/2J) 		decreased double-positive T cell number J:39328
Pnptm1Cmr/Pnptm1Cmr
(involves: 129) 		decreased double-positive T cell number J:62870
Pole3em3Tbo/Pole3em3Tbo
(FVB-Pole3em3Tbo) 		decreased double-positive T cell number J:298827
Polgtm1Prol/Polgtm1Prol
(B6J.129S7-Polgtm1Prol) 		decreased double-positive T cell number J:154187
Ppp4ctm1Tht/Ppp4ctm1Tht
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA) 		decreased double-positive T cell number J:117684
Ppp4ctm1Tht/Ppp4ctm1Tht
Tg(Lck-cre)548Jxm/0
Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6 * CBA) 		decreased double-positive T cell number J:117684
Prkchtm1.2Gasc/Prkchtm1.2Gasc
(involves: C57BL/6 * FVB/N * SJL) 		decreased double-positive T cell number J:186080
Prkchtm1.2Gasc/Prkchtm1.2Gasc
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		decreased double-positive T cell number J:186080
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy
Prkd3tm1.1Shoy/Prkd3tm1.1Shoy
Tg(Lck-cre)1Jtak/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J) 		increased double-positive T cell number J:236298
Prkdcscid/Prkdcscid
Tg(Tcrb)93Vbo/0
(involves: Balb/c * C57BL/Ka * C57BL/Lia * CBA/BrA) 		abnormal double-positive T cell morphology J:111476
Prkdctm1.1Bpcc/Prkdctm1.1Bpcc
(involves: 129 * C57BL/6) 		decreased double-positive T cell number J:171351
Prkdctm1Fwa/Prkdctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6) 		decreased double-positive T cell number J:50221
Prkdctm1Get/Prkdctm1Get
(involves: 129S4/SvJae * Black Swiss) 		increased double-positive T cell number J:50222
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp)a20Cwe/0
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased double-positive T cell number J:129512
Prss16tm1.1Mal/Prss16tm1.1Mal
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		decreased double-positive T cell number J:148034
Psme3tm1Jjm/Psme3tm1Jjm
(B6.129X1-Psme3tm1Jjm) 		decreased double-positive T cell number J:88626
Ptch1tm1Hahn/Ptch1tm1Hahn
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased double-positive T cell number J:127207
Ptcratm1(icre)Hjf/Ptcratm1(icre)Hjf
(B6.129P2-Ptcratm1(icre)Hjf) 		decreased double-positive T cell number J:197923
Ptcratm1.1Shoy/Ptcratm1.1Shoy
(involves: C57BL/6) 		decreased double-positive T cell number J:166147
Ptcratm1Vbo/Ptcratm1Vbo
(involves: 129P2/OlaHsd) 		abnormal double-positive T cell morphology J:123569
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(involves: 129S4/SvJae * BALB/c) 		decreased double-positive T cell number J:42595
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(C.129S4-Ptpn2tm1Mtr) 		decreased double-positive T cell number J:186843
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(B6.129S4(C)-Ptpn2tm1Mtr) 		decreased double-positive T cell number J:186843
Ptpn2tm2.1Ttig/Ptpn2tm2.1Ttig
(B6.Cg-Ptpn2tm2.1Ttig) 		decreased double-positive T cell number J:186843
Ptpn22tm1.1Draw/Ptpn22+
(involves: 129 * C57BL/6) 		increased double-positive T cell number J:201448
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
(involves: 129 * C57BL/6) 		increased double-positive T cell number J:201448
Ptpn22tm2Achn/Ptpn22tm2Achn
(B6.Cg-Ptpn22tm2Achn) 		abnormal double-positive T cell morphology J:147129
Ptpn22tm2Achn/Ptpn22tm2Achn
Ptprctm1Weis/Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn) 		abnormal double-positive T cell morphology J:147129
Ptprcloc/Ptprcloc
(C57BL/6JSfdAnu-Ptprcloc/AnuApb) 		abnormal double-positive T cell morphology J:104190
decreased double-positive T cell number J:104190
Ptprcltng/Ptprcltng
(C57BL/6-Ptprcltng) 		decreased double-positive T cell number J:158876
Ptprcltng/Ptprctm1Mak
(involves: 129/Sv * C57BL/6) 		decreased double-positive T cell number J:158876
Ptprctm1Holm/Ptprctm1Holm
(involves: 129/Sv * C57BL/6) 		decreased double-positive T cell number J:33466
Ptprctm1Tyb/Ptprctm1Tyb
(C.129S2-Ptprctm1Tyb) 		decreased double-positive T cell number J:57681
Ptprctm1Weis/Ptprctm1Weis
(B6.129X1-Ptprctm1Weis) 		abnormal double-positive T cell morphology J:147129
Rad21tm1.1Mmk/Rad21tm1.1Mmk
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6) 		decreased double-positive T cell number J:175827
Rag1/Rag2tm1Mnz/Rag1/Rag2tm1Mnz
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal double-positive T cell morphology J:90487
Rag1/Rag2tm1Mnz/Rag1/Rag2tm1Mnz
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal double-positive T cell morphology J:90487
Rag1tm1Jsek/Rag1+
(involves: 129S6/SvEvTac) 		decreased double-positive T cell number J:146912
Rag1tm1Jsek/Rag1tm1Jsek
(involves: 129S6/SvEvTac) 		decreased double-positive T cell number J:146912
Rag1tm1Mom/Rag1tm1Mom
Slc46a2tm1Moki/Slc46a2+
Tg(TcraB12,TcrbB12)1Rest/0
(involves: 129 * C57BL/6) 		decreased double-positive T cell number J:140121
Rag1tm1Mom/Rag1tm1Mom
Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S7/SvEvBrd * C3H/He * C57BL/6) 		increased double-positive T cell number J:135903
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		increased double-positive T cell number J:111874
Rag2tm1Avla/Rag2tm1Avla
(involves: 129/Sv * C57BL/6) 		decreased double-positive T cell number J:122108
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * MF1) 		decreased double-positive T cell number J:1935
Rag2tm1Fwa/Rag2tm1Fwa
TcrbLn3Jae/Tcrb+
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		increased double-positive T cell number J:143006
Rag2tm1Fwa/Rag2tm1Fwa
Tg(EmuSR-tTa)83Bop/0
Tg(tetO-Nfatct1*)1Grc/0
(involves: 129S/SvEv * C57BL/6J * CBA/J * FVB/N) 		abnormal double-positive T cell morphology J:141917
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Lck-Akt1*)M-1Pnt/0
(involves: 129S/SvEv * C3H/He * C57BL/6) 		increased double-positive T cell number J:135903
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Tcra5CC7,Tcrb5CC7)IWep/?
Themis5AT161/Themis5AT161
(involves: 129S/SvEv * C57BL/6) 		increased double-positive T cell number J:151076
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA/2) 		increased double-positive T cell number J:125548
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcrHEL3A9)1Mmd/0
(involves: 129S/SvEv * C57BL/6) 		abnormal double-positive T cell morphology J:78309
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: 129S/SvEv * C57BL/6) 		decreased double-positive T cell number J:78309
Rag2tm1Tgi/Rag2tm1Tgi
(involves: 129S1/Sv * 129X1/SvJ) 		decreased double-positive T cell number J:113641
Rasgrp1tm1.1Wz/Rasgrp1tm1.1Wz
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6J * DBA/2J) 		increased double-positive T cell number J:225109
Rasgrp1tm1Jstn/Rasgrp1tm1Jstn
(involves: 129P3/J) 		abnormal double-positive T cell morphology J:207898
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased double-positive T cell number J:99747
Relatm1Yuo/Relatm1Yuo
(involves: 129S/SvEv) 		decreased double-positive T cell number J:63099
Rhohtm1Brak/Rhohtm1Brak
(involves: 129/Sv * C57BL/6) 		decreased double-positive T cell number J:143161
Rhohtm1Brak/Rhohtm1Brak
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129/Sv * C57BL/6) 		decreased double-positive T cell number J:143161
Rhohtm1Daw/Rhohtm1Daw
(involves: 129 * C57BL/6) 		decreased double-positive T cell number J:113565
Rictortm1.1Klg/Rictortm1.1Klg
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Rictortm1.1Klg Tg(Mx1-cre)1Cgn) 		decreased double-positive T cell number J:189736
Rnf8Gt(AS0574)Wtsi/Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:161240
Rnf8Gt(RRR260)Byg/Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:161240
Rorctm1Amj/Rorctm1Amj
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2)) 		decreased double-positive T cell number J:64381
Rorctm1Litt/Rorctm1Litt
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:248565
Rorctm2Litt/Rorctm2Litt
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:87395
Rr38tm1.2Aafo/Rr38tm1.2Aafo
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6) 		decreased double-positive T cell number J:227747
Rr94tm3.1Litt/Rr94tm3.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		decreased double-positive T cell number J:158962
Rr94tm3.2Litt/Rr94tm3.2Litt
(involves: 129P2/OlaHsd * FVB/N) 		abnormal double-positive T cell morphology J:158962
decreased double-positive T cell number J:158962
Rr96tm1.1Tich/Rr96tm1.1Tich
Tg(ACTB-tTS)1Mllo/?
(involves: 129 * C57BL/6) 		decreased double-positive T cell number J:191711
Rr96tm1.1Yzo/Rr96tm1.1Yzo
(involves: 129P2/OlaHsd) 		increased double-positive T cell number J:130559
Rr96tm1Yzo/Rr96tm1Yzo
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased double-positive T cell number J:130559
Rr96tm1Yzo/Rr96tm1Yzo
Tg(Cd8a-cre,-GFP)1Yzo/?
(involves: 129P2/OlaHsd) 		increased double-positive T cell number J:130559
Rr97tm3Welm/Rr97tm3Welm
(involves: 129 * C57BL/6) 		abnormal double-positive T cell morphology J:126027
Rr100tm2.1Welm/Rr100tm2.1Welm
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:113136
Rr100tm2.1Welm/Rr100tm2.1Welm
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:158947
Rr395em1Bhao/Rr395em1Bhao
(Not Specified) 		decreased double-positive T cell number J:333961
Rr149356tm1.1Pf/Rr149356tm1.1Pf
(either: 129P2/OlaHsd-Rr149356tm1.1Pf or (involves: 129P2/OlaHsd * BALB/c)) 		decreased double-positive T cell number J:34311
Rr149356tm1Abnd/Rr149356tm1Abnd
(involves: 129S1/Sv * 129X1/SvJ) 		decreased double-positive T cell number J:137580
Rr149356tm1Che/Rr149356tm1Che
(involves: 129S4/SvJae * C57BL/6) 		abnormal double-positive T cell morphology J:106246, J:107306
Rr149356tm1Che/Rr149356tm1Che
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		abnormal double-positive T cell morphology J:106246
Runx1tm1(RUNX1)Gcg/Runx1tm1(RUNX1)Gcg
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		decreased double-positive T cell number J:106800
Runx1tm1Tani/Runx1tm1Tani
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal double-positive T cell morphology J:125959
Runx1tm1Tani/Runx1tm1Tani
Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:125959
Runx1tm1Yg/Runx1tm1Yg
(either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1)) 		increased double-positive T cell number J:125830
Runx1tm2Buch/Runx1tm2Buch
Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased double-positive T cell number J:105709
Runx1tm3Spe/Runx1tm3Spe
Tg(VAV1-cre)1Graf/0
(involves: 129S4/SvJae) 		decreased double-positive T cell number J:145700
Runx3tm1Litt/Runx3tm1Litt
(involves: 129P2/OlaHsd) 		abnormal double-positive T cell morphology J:141144
Ruvbl2M1Btlr/Ruvbl2+
(involves: C57BL/6J) 		decreased double-positive T cell number J:185495
Sash3tm1Hlz/Sash3tm1Hlz
(B6.129P2-Sash3tm1Hlz) 		decreased double-positive T cell number J:102171
Sgpl1Gt(OST58278)Lex/Sgpl1Gt(OST58278)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased double-positive T cell number J:145159
Shc1tm1Ravi/Shc1tm1Ravi
Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6) 		decreased double-positive T cell number J:78180
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ) 		decreased double-positive T cell number J:112817
Sit1tm1Lsmn/Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn) 		increased double-positive T cell number J:100408
Slatm1Weis/Slatm1Weis
(involves: 129 * C57BL/6) 		abnormal double-positive T cell morphology J:71804
Slc39a3tm1Gka/Slc39a3tm1Gka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased double-positive T cell number J:99161
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
Tg(Lck-cre)1Cwi/0
Tg(LCKprBCL2L1)12Sjk/0
(Not Specified) 		decreased double-positive T cell number J:144072
Smarca4tm1.2Pcn/Smarca4tm1Mag
Tg(Lck-cre)1Cwi/?
(involves: 129S/Sv * C57BL/6 * DBA/2) 		decreased double-positive T cell number J:85191
Smarca4tm1.2Pcn/Smarca4tm1Tich
Tg(Lck-cre)1Cwi/0
Tg(LCKprBCL2L1)12Sjk/0
(involves: 129) 		decreased double-positive T cell number J:144072
Smarca4tm1Tich/Smarca4+
Tg(Lck-cre)1Cwi/0
(involves: 129) 		decreased double-positive T cell number J:144072
Snai2tm2Grid/Snai2tm2Grid
Snai3tm1.2Jhws/Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6) 		decreased double-positive T cell number J:204710
Sos1tm1.1Les/Sos1tm1.1Les
Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6) 		decreased double-positive T cell number J:174536
Spi1tm1Ram/Spi1tm1Ram
(involves: 129S2/SvPas * C57BL/6) 		decreased double-positive T cell number J:36473
Srsf2tm1Xdfu/Srsf2tm1Xdfu
Tg(Lck-cre)I57Jxm/?
(involves: 129S4/SvJae * 129X1/SvJ * ICR) 		decreased double-positive T cell number J:88668
St14tm1Bug/St14tm1Bug
(involves: 129P2/OlaHsd * Black Swiss) 		decreased double-positive T cell number J:87125
Stk17btm1Hed/Stk17btm1Hed
(B6.129X1-Stk17btm1Hed) 		decreased double-positive T cell number J:94685
Supv3l1tm2.1Jkl/Supv3l1tm2.2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		decreased double-positive T cell number J:144991
Supv3l1tm2Jkl/Supv3l1tm2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:144991
Taf7tm1.1Dss/Taf7tm1.2Dss
Tg(Cd8a*-cre)B8Asin/0
(involves: C57BL/6) 		decreased double-positive T cell number J:185745
Taf7tm1.1Dss/Taf7tm1.2Dss
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6) 		decreased double-positive T cell number J:185745
Tasp1tm1Jjdh/Tasp1tm1Jjdh
Tg(Mx1-cre)1Cgn/?
(involves: 129X1/SvJ * C57BL/6 * CBA) 		decreased double-positive T cell number J:112159
Tcdel1C57BL/6/Tcdel1NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL) 		increased double-positive T cell number J:97046
Tcdel1NOD/ShiLtDoi/Tcdel1NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL) 		increased double-positive T cell number J:97046
Tcdel2C57BL/6/Tcdel2NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL) 		increased double-positive T cell number J:97046
Tcdel2NOD/ShiLtDoi/Tcdel2NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL) 		increased double-positive T cell number J:97046
Tcf3tm1Zhu/Tcf3tm1Zhu
(involves: 129 * C57BL/6J) 		decreased double-positive T cell number J:136143
Tcf4tm1Hmb/Tcf4tm1Zhu
Tg(Kit-cre)143Hmb/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased double-positive T cell number J:65236
Tcf7tm1Cle/Tcf7tm1Cle
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:23255
Tcf7tm2Cle/Tcf7tm2Cle
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:23255
Tcf12tm1Zhu/Tcf12tm1Zhu
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased double-positive T cell number J:136143
Tcf12tm2Zhu/Tcf12tm2Zhu
(Not Specified) 		decreased double-positive T cell number J:120411
Tcf12tm3Zhu/Tcf12tm3Zhu
Tcf3tm4Zhu/Tcf3tm4Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL/J) 		decreased double-positive T cell number J:129570
Tcra-Jtm1Kgwa/Tcra-Jtm1Kgwa
Tg(Tcrb2B4)1Mmd/0
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J) 		increased double-positive T cell number J:50143
Tcra-Jtm1Slek/Tcra-Jtm1Slek
(involves: 129P2/OlaHsd) 		decreased double-positive T cell number J:101398
TcraLn3Jae/Tcra+
(B6.Cg-TcraLn3Jae) 		decreased double-positive T cell number J:143006
TcraLn3Jae/Tcra+
TcrbLn3Jae/Tcrb+
(B6.Cg-TcrbLn3Jae TcraLn3Jae) 		decreased double-positive T cell number J:143006
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky
H2b/H2b
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		abnormal double-positive T cell morphology J:81564
decreased double-positive T cell number J:131357
Tcratm1Mom/Tcratm1Mom
Tcrbtm1Mom/Tcrbtm1Mom
(involves: 129 * BALB/c * C57BL/6) 		decreased double-positive T cell number J:3206
Tcrbtm1Mom/Tcrbtm1Mom
(involves: 129P2/OlaHsd * BALB/c) 		decreased double-positive T cell number J:3206
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129 * BALB/c * C57BL/6) 		decreased double-positive T cell number J:3206
Tdp2tm1.1Huy/Tdp2tm1.1Huy
(involves: 129P2/OlaHsd * CD-1) 		decreased double-positive T cell number J:195301
Tg(CD2-Mir181d)38Oers/0
(involves: C57BL/6) 		decreased double-positive T cell number J:212571
Tg(CD2-Myb/en)2Kmw/Tg(CD2-Myb/en)2Kmw
(involves: C57BL/10 * CBA) 		decreased double-positive T cell number J:126456
Tg(CD3E)26Cpt/Tg(CD3E)26Cpt
(involves: C57BL/6J * CBA/J) 		decreased double-positive T cell number J:54756
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6) 		decreased double-positive T cell number J:217939
Tg(Cd8aCd8b)3Erob/0
(involves: C57BL/6 * DBA/2) 		abnormal double-positive T cell morphology J:93004
Tg(DO11.10)10Dlo/?
(involves: BALB/c * C3H * C57BL/6) 		decreased double-positive T cell number J:70572
Tg(EEF1A1-SHC1*)1Ravi/?
Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6) 		decreased double-positive T cell number J:78180
Tg(H2-K-DUSP5)21Wjl/0
(involves: C57BL/6J * CBA) 		increased double-positive T cell number J:138077
Tg(Igk-Eik-H2-Ead)1Flv/0
Tg(Tcra1H3.1,Tcrb1H3.1)1Vire/0
(involves: C57BL/6 * SJL) 		decreased double-positive T cell number J:124574
Tg(Ins2-TFRC/OVA)296Wehi/0
Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased double-positive T cell number J:135154
Tg(ITGAL-Hhex)2Hro/0
(C3HeB/FeJ-Tg(ITGAL-Hhex)2Hro) 		decreased double-positive T cell number J:80777
Tg(KLK4mHEL)6Ccg/0
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		decreased double-positive T cell number J:78309
Tg(Lck-cre)548Jxm/?
Upf2tm1Btp/Upf2tm1Btp
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased double-positive T cell number J:134765
Tg(Lck-Hhex)1Hro/0
(C3HeB/FeJ-Tg(Lck-Hhex)1Hro) 		decreased double-positive T cell number J:80777
Tg(Lck-Sox13)#Jskg/0
(involves: C57BL/6) 		decreased double-positive T cell number J:117301
Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals) 		increased double-positive T cell number J:149973
Tg(LckIl4)1315Dbl/0
(involves: C57BL/6J * DBA/2J) 		decreased double-positive T cell number J:92453
Tg(ML5sHEL)5Ccg/0
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		decreased double-positive T cell number J:78309
Tg(ML5sHEL)5Ccg/0
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6JSfd * C57BL/10 * C57BR/cd) 		decreased double-positive T cell number J:78309
Tg(Pgk1-HA)1.1Vbo/?
Tg(Tcra/Tcrb)1Vbo/?
(involves: 129 * BALB/c * C57BL/6J * DBA/2J) 		increased double-positive T cell number J:125750
Tg(TCF3/HLF)1Mlc/0
(involves: FVB/N) 		decreased double-positive T cell number J:55022
Tg(Tcra2B4)1Mmd/?
(involves: C3H/HeJ * C57BL/6) 		decreased double-positive T cell number J:92992
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
Themistm1Lov/Themistm1Lov
(involves: 129 * C57BL/6 * DBA/2) 		increased double-positive T cell number J:151075
Tg(TcrAND)53Hed/?
(involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL) 		decreased double-positive T cell number J:85777
Tg(TcrAND)53Hed/?
Themistm1Gasc/Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		increased double-positive T cell number J:151074
Tg(TcrAND)53Hed/?
Themistm1Lov/Themistm1Lov
(involves: 129 * C57BL/6 * SJL) 		increased double-positive T cell number J:151075
Tg(TcraTcrb)1100Mjb/?
Themistm1Gasc/Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6) 		increased double-positive T cell number J:151074
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		abnormal double-positive T cell morphology J:78309
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		decreased double-positive T cell number J:78309
Tg(TcrLCMV)1Aox/?
(C57BL/6-Tg(TcrLCMV)1Aox) 		decreased double-positive T cell number J:92228
Tg(TcrLCMV)2Aox/?
(C57BL/6-Tg(TcrLCMV)2Aox) 		decreased double-positive T cell number J:92228
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2) 		decreased double-positive T cell number J:77696
Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6) 		decreased double-positive T cell number J:189197
Themistm1Gasc/Themistm1Gasc
(B6.129S-Themistm1Gasc) 		increased double-positive T cell number J:151074
Tle4tm1.2Dasw/Tle4tm1.2Dasw
(B6.129S6(Cg)-Tle4tm1.2Dasw) 		decreased double-positive T cell number J:219243
Tnfsf12tm1Ash/Tnfsf12tm1Ash
(B6.129-Tnfsf12tm1Ash) 		increased double-positive T cell number J:104801
Tpp2tm1.1Gnie/Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6) 		decreased double-positive T cell number J:133572
Traf2tm1Mak/Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J)) 		decreased double-positive T cell number J:44360
Traf3tm1Bal/Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J) 		decreased double-positive T cell number J:37065
Traf3ip3tm1b(KOMP)Wtsi/Traf3ip3tm1b(KOMP)Wtsi
(involves: BALB/cJ * C57BL/6N) 		increased double-positive T cell number J:226431
TsilTg(Myc)12ALvn/TsilTg(Myc)12ALvn
(involves: C57BL/6 * SJL/J) 		increased double-positive T cell number J:33857
Twsg1tm1Nosa/Twsg1tm1Nosa
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:82738
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas) 		decreased double-positive T cell number J:79323
Vav1tm1Tyb/Vav1tm1Tyb
(either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)) 		decreased double-positive T cell number J:190087
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * 129S2/SvPas) 		decreased double-positive T cell number J:86654
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Kdf/Vav2tm1Kdf
Vav3tm1Swat/Vav3tm1Swat
(involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6) 		decreased double-positive T cell number J:86654
Vav1tm1Tyb/Vav1tm1Tyb
Vav3tm1Swat/Vav3tm1Swat
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6) 		decreased double-positive T cell number J:86654
Vav1tm2Bbd/Vav1tm2Bbd
(B6.129-Vav1tm2Bbd) 		decreased double-positive T cell number J:141390
Wastm1Kas/Wastm1Kas
(involves: 129/Sv * C57BL/6) 		decreased double-positive T cell number J:87875
Wastm1Sbs/Wastm1Sbs
(involves: 129S6/SvEvTac) 		abnormal double-positive T cell morphology J:125309
Wastm1Sbs/Wastm1Sbs
Wasltm2Sbs/Wasltm2Sbs
Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal double-positive T cell morphology J:125309
Wlstm1.1Arte/Wlstm1.1Arte
Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased double-positive T cell number J:202499
Xrcc6tm1Fwa/Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J) 		increased double-positive T cell number J:44361
Zap70mrtle/Zap70mrtle
(involves: C57BL/6JSfdAnu) 		abnormal double-positive T cell morphology J:211510
increased double-positive T cell number J:211510
Zap70mrtle/Zap70rps
(involves: C57BL/6 * C57BL/6JSfdAnu) 		abnormal double-positive T cell morphology J:211510
increased double-positive T cell number J:211510
Zap70tm1Dlo/Zap70tm1Dlo
(involves: 129P2/OlaHsd) 		increased double-positive T cell number J:97610
Zbtb1m1Btlr/Zbtb1m1Btlr
(involves: C3H/HeN * C57BL/6J) 		decreased double-positive T cell number J:178820
Zbtb7atm1Ppp/Zbtb7atm2Ppp
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		abnormal double-positive T cell morphology J:121576
Zbtb7btm1Litt/Zbtb7btm1.2Litt
(involves: C57BL/6) 		abnormal double-positive T cell morphology J:141144
Zeb1m1Btlr/Zeb1m1Btlr
(involves: C57BL/6J) 		decreased double-positive T cell number J:185495
Zeb1tm1Yhi/Zeb1tm1Yhi
(B6.129P2-Zeb1tm1Yhi) 		decreased double-positive T cell number J:39865
Zfp131tm1.1Mytk/Zfp131tm1.2Mytk
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6N * FVB/N) 		decreased double-positive T cell number J:271921
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/16/2024
MGI 6.23 		The Jackson Laboratory